PDS Biotechnology Corp Other Non-Current Assets
PDS Biotechnology Corp (PDSB) had Other Non-Current Assets of $0 as of 2019-12-31, per its 10-K filed 2020-03-27.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2020-03-27
- 2019-12-31: Other Assets, Noncurrent $0.00.
- 2019-09-30: Other Assets, Noncurrent $0.00.
- 2019-06-30: Other Assets, Noncurrent $145.47K.
- 2019-03-31: Other Assets, Noncurrent $155.67K.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-27 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $145.47K 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $155.67K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $12.80K 10-K · filed 2020-03-27 | $142.87K 10-K · filed 2019-02-21 |
| 2018-09-30 | $142.87K 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $142.87K 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $142.87K 10-Q · filed 2018-05-01 | |
| 2017-12-31 | $142.87K 10-K · filed 2019-02-21 | |
| 2017-09-30 | $142.87K 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $142.87K 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $142.87K 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $142.87K 10-K · filed 2018-03-01 | |
| 2016-09-30 | $142.87K 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $142.87K 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $142.87K 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $55.16K 10-K · filed 2017-03-02 | |
| 2015-09-30 | $104.24K 10-Q · filed 2015-11-06 | |
| 2014-12-31 | $55.16K 10-K · filed 2016-03-08 | $160.68K 10-Q · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |